Association of Symptoms After COVID-19 Vaccination With Anti-SARS-CoV-2 Antibody Response in the Framingham Heart Study
- PMID: 36269359
- PMCID: PMC9587476
- DOI: 10.1001/jamanetworkopen.2022.37908
Association of Symptoms After COVID-19 Vaccination With Anti-SARS-CoV-2 Antibody Response in the Framingham Heart Study
Erratum in
-
Error in Figure and Discussion.JAMA Netw Open. 2022 Nov 1;5(11):e2247057. doi: 10.1001/jamanetworkopen.2022.47057. JAMA Netw Open. 2022. PMID: 36441556 Free PMC article. No abstract available.
Plain language summary
This cohort study examines the association of self-reported postvaccination symptoms with anti–SARS-CoV-2 antibody response among Framingham Heart Study participants contributing to the Collaborative Cohort of Cohorts for COVID-19 Research study.
Conflict of interest statement
Figures
Similar articles
-
Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects.Microbiol Spectr. 2021 Sep 3;9(1):e0034121. doi: 10.1128/Spectrum.00341-21. Epub 2021 Aug 4. Microbiol Spectr. 2021. PMID: 34346750 Free PMC article.
-
Efficacy of antibody response following the vaccination of SARS-CoV-2 infected and noninfected healthcare workers by two-dose inactive vaccine against COVID-19.J Med Virol. 2022 Jun;94(6):2431-2437. doi: 10.1002/jmv.27649. Epub 2022 Feb 14. J Med Virol. 2022. PMID: 35128700 Free PMC article.
-
Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study.Viruses. 2022 Oct 31;14(11):2416. doi: 10.3390/v14112416. Viruses. 2022. PMID: 36366515 Free PMC article.
-
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel Disease.Clin Gastroenterol Hepatol. 2024 Jul;22(7):1475-1486.e4. doi: 10.1016/j.cgh.2024.02.001. Epub 2024 Feb 17. Clin Gastroenterol Hepatol. 2024. PMID: 38369224
-
Influence of age, gender, previous SARS-CoV-2 infection, and pre-existing diseases in antibody response after COVID-19 vaccination: A review.Mol Immunol. 2023 Apr;156:148-155. doi: 10.1016/j.molimm.2023.03.007. Epub 2023 Mar 10. Mol Immunol. 2023. PMID: 36921489 Free PMC article. Review.
Cited by
-
Association between adverse events after COVID-19 vaccination and anti-SARS-CoV-2 antibody concentrations, the Netherlands, May 2021 to November 2022: a population-based prospective cohort study.Euro Surveill. 2024 Jun;29(25):2300585. doi: 10.2807/1560-7917.ES.2024.29.25.2300585. Euro Surveill. 2024. PMID: 38904110 Free PMC article.
-
Innate Responses to the Former COVID-19 Vaccine Candidate CVnCoV and Their Relation to Reactogenicity and Adaptive Immunogenicity.Vaccines (Basel). 2024 Apr 6;12(4):388. doi: 10.3390/vaccines12040388. Vaccines (Basel). 2024. PMID: 38675770 Free PMC article.
-
No Evidence That Analgesic Use after COVID-19 Vaccination Negatively Impacts Antibody Responses.Immunohorizons. 2023 Dec 1;7(12):834-841. doi: 10.4049/immunohorizons.2300090. Immunohorizons. 2023. PMID: 38085168 Free PMC article.
-
The Novavax Heterologous Coronavirus Disease 2019 Booster Demonstrates Lower Reactogenicity Than Messenger RNA: A Targeted Review.J Infect Dis. 2024 Aug 16;230(2):e496-e502. doi: 10.1093/infdis/jiad519. J Infect Dis. 2024. PMID: 37992183 Free PMC article. Review.
-
Side Effects of COVID-19 Vaccines in Pregnant and Lactating Mexican Women and Breastfed Infants: A Survey-Based Study.Vaccines (Basel). 2023 Jul 25;11(8):1280. doi: 10.3390/vaccines11081280. Vaccines (Basel). 2023. PMID: 37631848 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
